Live
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
£608,000,000
NHS EnglandITH Pharma
services
Contract Details
- Tender Value
- £608,000,000
- Stage
- Live
- Published
- Awarded
Timeline
Awarded
Start
Disclosed
End
Description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Related Contracts
From This Buyer
- Oracle Aconex Connected Cost Primavera 6 OPC Virtual Desktop
£360,770 ·
- Modelling of the NHS Estates Utilisation
£50,000 ·
- Amos into action
£350,000 ·
- Social Media Relationship Platform 2026 27
£126,000 ·
From This Supplier
In This Category
- Planning System
£336,200 ·
- QOC907 09:00 2026-08-05 Thurston & Bury St Edmunds to In Toto Education, Ely, Cambs - AWARD
£162,336 ·
- Provision of Services for Change Capability Enablement and Portfolio Insights
£1,000,000 ·
- QNT019 09:00 2026-08-03 Haverhill to Polaris @ Newmarket Academy, Newmarket - AWARD
£68,400 ·
Ref: 5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287 · Sourced from Contracts Finder
View source notice